Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ganeval

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Medicine|September 1, 1979
Immunologically-mediated acute renal failure of nonglomerular origin in the course of systemic lupus erythematosus [SLE]. Report of two casesF Tron, D Ganeval, D Droz
La Nouvelle Presse Medicale|March 19, 1977
[Nephrotoxicity of gentamicin. Conditions for the use of this antibiotic in the elderly and in the patient with renal insufficiency]P Jungers, D Ganeval, D Kleinknecht
American Journal of Clinical Pathology|June 1, 1987
Immunohistochemical characterization of renal amyloidosisL H Noel, D Droz, D Ganeval
The American Journal of Medicine|May 23, 1986
Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosinP Jungers, D Ganeval, N Pertuiset, et al.
American Journal of Nephrology|January 1, 1990
Proteinuria in multiple myeloma and related diseasesD Ganeval, B Lacour, N Chopin, et al.
British Medical Journal (Clinical Research Ed.)|February 28, 1981
Systemic lambda light-chain deposition in a patient with myelomaD Ganeval, L H Noël, D Droz, et al.
Nephron|January 1, 1976
Furosemide in acute oliguric renal failure. A controlled trialD Kleinknecht, D Ganeval, L A Gonzalez-Duque, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairmentP Jungers, D Ganeval, T Hannedouche, et al.
Clinical Nephrology|May 1, 1984
Renal granular monoclonal light chain deposits: morphological aspects in 11 casesL H Noel, D Droz, D Ganeval, et al.
Diabetes|January 1, 1982
Diabetes mellitus following pentamidine-induced hypoglycemia in humansP Bouchard, P Sai, G Reach, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|September 1, 1979
Immunologically-mediated acute renal failure of nonglomerular origin in the course of systemic lupus erythematosus [SLE]. Report of two casesF Tron, D Ganeval, D Droz
La Nouvelle Presse Medicale|March 19, 1977
[Nephrotoxicity of gentamicin. Conditions for the use of this antibiotic in the elderly and in the patient with renal insufficiency]P Jungers, D Ganeval, D Kleinknecht
American Journal of Clinical Pathology|June 1, 1987
Immunohistochemical characterization of renal amyloidosisL H Noel, D Droz, D Ganeval
The American Journal of Medicine|May 23, 1986
Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosinP Jungers, D Ganeval, N Pertuiset, et al.
American Journal of Nephrology|January 1, 1990
Proteinuria in multiple myeloma and related diseasesD Ganeval, B Lacour, N Chopin, et al.
British Medical Journal (Clinical Research Ed.)|February 28, 1981
Systemic lambda light-chain deposition in a patient with myelomaD Ganeval, L H Noël, D Droz, et al.
Nephron|January 1, 1976
Furosemide in acute oliguric renal failure. A controlled trialD Kleinknecht, D Ganeval, L A Gonzalez-Duque, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairmentP Jungers, D Ganeval, T Hannedouche, et al.
Clinical Nephrology|May 1, 1984
Renal granular monoclonal light chain deposits: morphological aspects in 11 casesL H Noel, D Droz, D Ganeval, et al.
Diabetes|January 1, 1982
Diabetes mellitus following pentamidine-induced hypoglycemia in humansP Bouchard, P Sai, G Reach, et al.
Pageof 3